Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change

Q4 Medicine
A. A. Antonov, S. Vostrukhin, A. V. Volzhanin, A. A. Vitkov, A. M. Akimov, I. I. Asinovskova
{"title":"Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change","authors":"A. A. Antonov, S. Vostrukhin, A. V. Volzhanin, A. A. Vitkov, A. M. Akimov, I. I. Asinovskova","doi":"10.32364/2311-7729-2022-22-2-103-107","DOIUrl":null,"url":null,"abstract":"Aim: to assess the effects of prostaglandin F2a analogues on intraocular pressure (IOP) fluctuations when changing body position. Patients and Methods: thirty-eight patients (50 eyes) with newly diagnosed primary open-angle glaucoma (POAG). Patients were examined before and one month after prescribing travoprost, a prostaglandin F2a analogue. During the examination, IOP was measured by Icare pro rebound tonometry and applanation tonometry (corneal-compensated IOP/ccIOP and Goldmann-correlated IOP/IOPg) in a sitting position. Next, IOP was measured by Icare tonometer twice with a 5-min interval in a supine position. Finally, IOP was measured by Icare tonometry and applanation tonometry (IOPcc, IOPg) in the sitting position. Results: baseline IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.3 mm Hg, and 22.9±3.4 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 23.7±3.3 mm Hg and 24.0±3.3 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.4 mm Hg, and 22.3±3.4 mm Hg. One month after starting treatment with travoprost, IOPcc, IOPg, and IOP measured by Icare reduced to 18.2±2.7 mm Hg, 18.2±1.8 mm Hg, and 16.6±2.5 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 17.3±2.8 mm Hg and 17.2±2.7 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 18.0±2.3 mm Hg, 18.4±1.8 mm Hg, and 16.2±2.5 mm Hg, respectively. When transiting in a supine position, the differences in IOP levels were 0.83±1.04 mm Hg at baseline and 0.77±1.41 mm Hg after one month. When transiting in a sitting position, the differences in IOP levels were 1.66±1.24 mm Hg at baseline and 0.99±0. 98 mm Hg after one month. Conclusion: travoprost as a starting monotherapy for POAG provides a long-lasting IOP reduction and minimizes its fluctuations when changing body position Keywords: glaucoma, intraocular pressure, body position, rebound tonometry, prostaglandin analogue, travoprost. For citation: Antonov A.A., Vostrukhin S.V., Volzhanin A.V. et al. Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change. Russian Journal of Clinical Ophthalmology. 2022;22(2):103–107 (in Russ.). DOI: 10.32364/2311-7729-2022- 22-2-103-107.","PeriodicalId":36455,"journal":{"name":"Russian Journal of Clinical Ophthalmology","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Clinical Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32364/2311-7729-2022-22-2-103-107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4

Abstract

Aim: to assess the effects of prostaglandin F2a analogues on intraocular pressure (IOP) fluctuations when changing body position. Patients and Methods: thirty-eight patients (50 eyes) with newly diagnosed primary open-angle glaucoma (POAG). Patients were examined before and one month after prescribing travoprost, a prostaglandin F2a analogue. During the examination, IOP was measured by Icare pro rebound tonometry and applanation tonometry (corneal-compensated IOP/ccIOP and Goldmann-correlated IOP/IOPg) in a sitting position. Next, IOP was measured by Icare tonometer twice with a 5-min interval in a supine position. Finally, IOP was measured by Icare tonometry and applanation tonometry (IOPcc, IOPg) in the sitting position. Results: baseline IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.3 mm Hg, and 22.9±3.4 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 23.7±3.3 mm Hg and 24.0±3.3 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.4 mm Hg, and 22.3±3.4 mm Hg. One month after starting treatment with travoprost, IOPcc, IOPg, and IOP measured by Icare reduced to 18.2±2.7 mm Hg, 18.2±1.8 mm Hg, and 16.6±2.5 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 17.3±2.8 mm Hg and 17.2±2.7 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 18.0±2.3 mm Hg, 18.4±1.8 mm Hg, and 16.2±2.5 mm Hg, respectively. When transiting in a supine position, the differences in IOP levels were 0.83±1.04 mm Hg at baseline and 0.77±1.41 mm Hg after one month. When transiting in a sitting position, the differences in IOP levels were 1.66±1.24 mm Hg at baseline and 0.99±0. 98 mm Hg after one month. Conclusion: travoprost as a starting monotherapy for POAG provides a long-lasting IOP reduction and minimizes its fluctuations when changing body position Keywords: glaucoma, intraocular pressure, body position, rebound tonometry, prostaglandin analogue, travoprost. For citation: Antonov A.A., Vostrukhin S.V., Volzhanin A.V. et al. Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change. Russian Journal of Clinical Ophthalmology. 2022;22(2):103–107 (in Russ.). DOI: 10.32364/2311-7729-2022- 22-2-103-107.
前列腺素类似物对体位变化时眼压波动的影响
目的:探讨前列腺素F2a类似物对体位变化时眼压波动的影响。患者与方法:新诊断原发性开角型青光眼(POAG) 38例(50眼)。患者在开曲伏前列素(一种前列腺素F2a类似物)处方前和处方后一个月接受检查。检查时,采用Icare pro反跳眼压仪和压平眼压仪(角膜代偿眼压/ccIOP和goldmann相关眼压/IOPg)在坐位测量眼压。然后,在仰卧位用Icare眼压仪测量眼压2次,间隔5分钟。最后,采用Icare眼压仪和眼压仪(IOPcc, IOPg)测量坐位眼压。结果:Icare测量的基线IOPcc、IOPg和IOP分别为25.4±3.2 mm Hg、25.7±2.3 mm Hg和22.9±3.4 mm Hg。仰卧位IOP (Icare眼压)分别为23.7±3.3 mm Hg和24.0±3.3 mm Hg。在坐位重复测量时,Icare测得的IOPcc、IOPg和IOP分别为25.4±3.2 mm Hg、25.7±2.4 mm Hg和22.3±3.4 mm Hg。曲伏前列素治疗1个月后,Icare测得的IOPcc、IOPg和IOP分别降至18.2±2.7 mm Hg、18.2±1.8 mm Hg和16.6±2.5 mm Hg。仰卧位IOP (Icare血压计)分别为17.3±2.8 mm Hg和17.2±2.7 mm Hg。在坐位重复测量时,Icare测得的IOPcc、IOPg和IOP分别为18.0±2.3 mm Hg、18.4±1.8 mm Hg和16.2±2.5 mm Hg。当采用仰卧位时,IOP水平的差异在基线时为0.83±1.04 mm Hg,一个月后为0.77±1.41 mm Hg。当以坐姿转换时,IOP水平的差异为基线时的1.66±1.24 mm Hg和0.99±0。一个月后98毫米汞柱。结论:曲伏前列素作为POAG的起始单药治疗可提供持久的IOP降低,并最大限度地减少体位变化时的IOP波动。关键词:青光眼,眼压,体位,反跳眼压测量,前列腺素类似物,曲伏前列素。引证:Antonov a.a., Vostrukhin s.v., Volzhanin A.V.等。前列腺素类似物对体位变化时眼压波动的影响。俄罗斯临床眼科学杂志,2022;22(2):103-107。Doi: 10.32364/2311-7729-2022- 22-2-103-107。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
21
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信